Why are more young adults being diagnosed with colorectal cancer?
Picture this: you’re 40, busy with work and family, and you start noticing a little blood “in the toilet.” Someone says, “It’s probably hemorrhoids,” you get a cream, and life goes on. Months later, you finally get a colonoscopy, and the word cancer walks into the room with you.
That’s a scene I’m seeing more and more often in clinic. Globally, colorectal cancer is now the third most common cancer and the second leading cause of cancer death (He et al., 2025; Chen et al., 2025; Bray et al., 2024). But what’s really striking is the rise in people under 50.
In the U.S., early-onset colorectal cancer increased by about 63% between 1988 and 2015, from 7.9 to 12.9 cases per 100,000 people (Sinicrope, 2022). Similar trends are now being reported in Asia and Latin America (Sung et al., 2024).
People born after 1960 face a much higher lifetime risk than previous generations, and those born in the 1990s may have up to a five-fold higher risk of early-onset colon cancer than those born in 1960 (Downham et al., 2025). That’s not about one person “being unlucky”; it’s a cohort effect — the environment and lifestyle we share as a generation.
So the real question is: what has changed in our food, movement, sleep and exposures — starting in childhood — that’s moving colorectal cancer into younger decades of life?
What is “early-onset” colorectal cancer?
Early-onset colorectal cancer means being diagnosed before age 50. Within that range, risk increases with every year — 48 is not the same as 32, even though both are “under 50” (Javidi et al., 2026).
A few key points:
- About 16–25% of young patients carry a pathogenic germline mutation in a cancer susceptibility gene (especially Lynch syndrome and familial adenomatous polyposis), versus ~10% in older adults (Jayakrishnan & Ng, 2025).
- Still, 60–75% of young cases do not report a clear family history, which means lifestyle and environmental factors are doing a lot of the heavy lifting (Stoffel & Murphy, 2019).
- Many of those risk factors start acting early in life: an ultra-processed diet, sugary drinks, the explosion of childhood obesity, low physical activity, disrupted sleep, and early antibiotic exposure (Sung et al., 2024; Grewal et al., 2023; Rubin, 2025).
Cancer usually takes years to develop. What you did — or what was done to your body — at 10, 15 or 20 years old may show up in your colon at 40.
How lifestyle raises or lowers your risk
Food and drinks
The Western dietary pattern — high in processed and red meats, refined grains, high-fat dairy, sugary drinks and ultra-processed snacks — is strongly linked to early high-risk adenomas and colorectal cancer (Hua et al., 2023; Chu et al., 2025).
Some striking numbers:
- Women drinking two or more sugary drinks a day had about double the risk of early-onset colorectal cancer compared with those drinking less than one a week (RR 2.18) (Sinicrope, 2022; Hua et al., 2023).
- Each extra daily serving of sugary beverages during ages 13–18 increased risk by 32% later in life (Sinicrope, 2022).
- Long-term intake of processed meat is clearly linked to higher risk; roughly 13% of colorectal cancers may be attributable to processed meat in some analyses (Chu et al., 2025).
On the protective side, several eating patterns share the same backbone:
- Mediterranean-style diets (lots of plants, olive oil, fish, little red and processed meat).
- High scores on Healthy Eating Index / Alternate Healthy Eating Index.
- Healthy plant-based diets and DASH-style diets.
They all emphasize:
- Vegetables, fruits, whole grains, legumes, nuts and seeds.
- Healthier protein sources (beans, fish, poultry).
- Healthy fats (olive oil and other unsaturated fats).
- Minimal added sugars, saturated fats and excess calories (Chu et al., 2025).
These patterns are associated with lower colorectal cancer risk and a 7–18% reduction in cancer-related mortality.
Movement, sitting time and weight
Regular physical activity is one of your most powerful tools:
- 150–300 minutes of moderate activity per week or 75–150 minutes vigorous is the standard recommendation and is linked to lower colorectal cancer risk (ACS, 2025; Sinicrope, 2022).
- In a cohort followed for up to 32 years, sticking to activity guidelines (about 17 MET-hours/week, roughly 5–6 hours of brisk walking) significantly reduced digestive system cancers (Laskar et al., 2025).
- Occupational, recreational, transport-related and household activity all help; relative risks for colon cancer in the most active vs least active range from 0.66 to 0.85 (Grewal et al., 2023; Hua et al., 2023).
Sitting, especially for long stretches, pulls in the opposite direction:
- Sedentary work is associated with higher colon cancer risk (RR 1.44) (Grewal et al., 2023).
- Watching TV more than 14 hours per week vs less than 7 was linked to an RR 1.69 for early-onset colorectal cancer (Hua et al., 2023).
Weight matters too:
- Obesity (BMI ≥30): OR ≈1.88 for early-onset colorectal cancer.
- Overweight (BMI 25–29.9): OR ≈1.32 (Hua et al., 2023).
- Childhood and adolescent obesity, and maternal obesity during pregnancy, also increase risk (Sinicrope, 2022; Laskar et al., 2025).
One large study estimated that about 45% of colorectal cancers could be attributed to not adhering to five simple lifestyle behaviors: not smoking, low alcohol, healthy diet, regular activity and healthy body weight (Carr et al., 2018).
Tobacco, alcohol and metabolic health
- Smoking: OR 1.44–2.14 for early-onset colorectal cancer, with particularly high risk for advanced left-sided lesions (Hua et al., 2023; Gausman et al., 2020). Quitting earlier lowers risk over time.
- Alcohol: every 10 g/day of ethanol raises risk by around 7%; moderate-to-high drinking is linked with more colorectal cancer (Chu et al., 2025; Hua et al., 2023).
- Metabolic syndrome, hypertension, high triglycerides and MASLD (metabolic dysfunction–associated fatty liver disease) each add their own piece to the risk puzzle (Hua et al., 2023; Jayakrishnan & Ng, 2025).
Genetics, family history and medical conditions
Hereditary syndromes explain a sizeable portion of early-onset colorectal cancers — up to one in five young patients may carry a germline mutation in a cancer susceptibility gene (Jayakrishnan & Ng, 2025; Sinicrope, 2022).
Major syndromes include:
- Lynch syndrome: about 3% of all colorectal cancers, but up to a third of cases under age 35. Lifetime colon cancer risk 15–52%, depending on the gene (MLH1, MSH2, MSH6, PMS2, EPCAM) (Stoffel et al., 2018; Sinicrope, 2022).
- Familial adenomatous polyposis (FAP): caused by APC mutations; without treatment, colorectal cancer risk approaches 100%.
- Other polyposis syndromes: MUTYH-associated polyposis, Peutz–Jeghers (STK11), juvenile polyposis (SMAD4), Li–Fraumeni (TP53) and others, each with high lifetime colon cancer risks (Jayakrishnan & Ng, 2025).
Family history still matters even when no syndrome is formally identified:
- About 28–30% of early-onset patients report at least one first-degree relative with colorectal cancer, compared to 8–19% in later-onset cases (Jayakrishnan & Ng, 2025).
- Having ≥1 first-degree relative with colorectal cancer gives a relative risk of about 1.76–2.26 (Issaka et al., 2023).
Conditions like inflammatory bowel disease also raise risk; young adults with early-onset colorectal cancer are more likely to have a history of IBD, with an OR around 2.97 (Gausman et al., 2020).
Because of this, expert groups recommend germline multigene panel testing for all patients diagnosed before 50, regardless of family history (NCCN, 2025; Cavestro et al., 2023). Pre- and post-test genetic counseling helps people understand results, manage anxiety, and organize cascade testing for at-risk relatives (Lindor et al., 2006; Hibbert et al., 2025).
Screening: when should I start?
For average-risk adults in the U.S., the American Cancer Society and others now recommend starting screening at age 45. The USPSTF gives a B-grade recommendation for ages 45–49, and an A-grade for 50–75 (Davidson et al., 2021). Modeling studies suggest that starting at 45 instead of 50 adds 22–27 life-years per 1,000 people screened.
Main options:
- Stool-based tests
- Annual FIT.
- Multitarget stool DNA every 3 years.
- Direct visualization
- Colonoscopy every 10 years (gold standard; detects and removes precancerous polyps).
- Flexible sigmoidoscopy every 5 years.
- CT colonography every 5 years.
If you have a strong family history, the American Gastroenterological Association and other societies suggest:
- ≥1 first-degree relative with colorectal cancer or advanced adenoma before 60, or ≥2 first-degree relatives at any age: colonoscopy every 5 years, starting at age 40 or 10 years before the youngest diagnosis (Issaka et al., 2023; NCCN, 2025).
- One first-degree relative diagnosed at ≥60: start at 40 with any recommended modality, using average-risk intervals.
If you have a hereditary syndrome, screening usually starts much earlier and is more intensive; for example, annual colonoscopy from age 10–15 in classic FAP, or from the late teens/early 20s in Lynch syndrome (NCCN, 2025).
Remember: guideline ages vary by country, and your personal plan should be tailored with your doctor.
Red-flag symptoms: too young does not mean “too young for cancer”
No matter how old you are, certain symptoms should always trigger a serious look at your colon:
- Rectal bleeding — especially blood mixed in with the stool, not just on the toilet paper.
- Persistent abdominal pain that doesn’t have an obvious explanation.
- New change in bowel habits (diarrhea, constipation, pencil-thin stools) lasting more than a few weeks.
- Iron-deficiency anemia without a clear cause.
- Unintentional weight loss.
In studies of early-onset colorectal cancer, about 45–46% of patients had rectal bleeding, 40–55% had abdominal pain, around 30% had bowel habit changes, and 10–35% experienced weight loss before diagnosis (Fritz et al., 2023; Demb et al., 2024; Eng et al., 2022).
Yet, the time from first symptom to diagnosis is often 4–6 months, and in about 20% of patients, symptoms are present 3 months to 2 years before the cancer is found (Fritz et al., 2023; Demb et al., 2024).
If you notice these signs, don’t let anyone dismiss them just because you’re under 50. Ask directly:
“Could this be my colon? Do I need a colonoscopy or another test to rule out cancer?”
Do lifestyle changes still matter if I have high genetic risk?
Yes — they do. They may not bring your risk down to “average,” but they can make a big difference.
In a large population-based study, people who adhered to five healthy lifestyle factors (no smoking, limited alcohol, healthy diet, regular exercise, healthy weight) had a 67% lower risk of colorectal cancer (OR 0.33), regardless of genetic risk score, colonoscopy history or family history (Carr et al., 2018).
In Lynch syndrome specifically:
- Obesity nearly doubles or more than doubles colon cancer risk (HR 2.38) (Power et al., 2023).
- Higher physical activity is associated with roughly 29% risk reduction (Dashti et al., 2018).
- Smoking increases risk (HR 1.43) (Lindor et al., 2006).
Because of this, guidelines like those from the NCCN and **World Cancer Research Fund / American Institute for Cancer Research emphasize the same basics for everyone — with or without a genetic mutation:
- Stay physically active.
- Eat mostly plants (vegetables, fruits, whole grains, legumes).
- Limit red and processed meats.
- Avoid sugary drinks and highly processed foods.
- Avoid smoking.
- Keep alcohol intake low or none.
- Maintain a healthy weight (WCRF/AICR; Chu et al., 2025).
For some people with Lynch syndrome, daily aspirin may be considered as a preventive medication. In the CAPP2 trial, 600 mg/day for at least 2 years reduced colon cancer risk significantly (HR 0.56 per protocol; Burn et al., 2020).
However, this is a high dose and comes with bleeding risks — it’s a decision to make with a specialist, not something to start on your own.
What you can do this week
- Map your family tree.
Write down who had colon or rectal cancer, polyps, or related cancers and at what age. Bring it to your next visit. - Schedule a conversation, not just a test.
Ask your primary care doctor when you should start screening and which test is best for you, given your risk. - Audit your plate.
- Half your plate as vegetables and fruits.
- About a third as whole grains.
- The rest as lean protein (fish, poultry, beans, low-fat dairy).
Cut back on processed meats, sugary drinks and ultra-processed snacks.
- Shrink your sitting time.
Add short walking breaks, aim for at least 10–15 minutes of brisk walking most days, and build up from there. - Watch for red flags.
If you see rectal bleeding, persistent bowel changes, unexplained fatigue or weight loss, push for proper evaluation.
What if you start now?
If you start making changes now and get screened on time, the impact can be profound: fewer emergency surgeries, fewer advanced cancers, more years feeling well and present with the people you love.
Here at Dr. Dándote Salud (Here’s to better health), our philosophy is simple: Choose health. Choose life. You can’t rewrite the genes you were born with, but you can absolutely rewrite the next chapters of your health story.
I’d love to hear from you:
Does colorectal cancer run in your family? What feels harder right now — changing how you eat, moving more, or asking for a colonoscopy?
Share your thoughts in the blog comments. Your story and questions might shape our next article or our “question of the month.”
Scientific Sources
(I’ve listed the main sources that support what you’ve just read. You can share this section with your doctor if you’d like to explore the evidence).
Epidemiology and trends
- He Y, Wang X, Zhou M, et al. Global, Regional and National Burden of Colon and Rectum Cancer: GBD 2021 with projections to 2036. BMJ Open. 2025.
- Chen X, Tian R, Chen Z, Quan L, Bei S. Global Burden of Colorectal Cancer From 1990 to 2021. Front Oncol. 2025.
- Tian S, Wang YS, Wei D. The Global, Regional, and National Burden of Colorectal Cancer and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2021. Front Oncol. 2025.
- Morgan E, Arnold M, Gini A, et al. Global Burden of Colorectal Cancer in 2020 and 2040. Gut. 2023.
- Bray F, Laversanne M, Sung H, et al. Global Cancer Statistics 2022: GLOBOCAN Estimates. CA Cancer J Clin. 2024.
- Sung H, Siegel RL, Laversanne M, et al. Colorectal cancer incidence trends in younger versus older adults. Lancet Oncol. 2024.
- Downham L, Laversanne M, Perdomo S, et al. Increase of Early-Onset Colorectal Cancer: A Cohort Effect. J Natl Cancer Inst. 2025.
Early-onset disease: risk factors and red-flag symptoms
- Sinicrope FA. Increasing Incidence of Early-Onset Colorectal Cancer. N Engl J Med. 2022.
- Hua H, Jiang Q, Sun P, Xu X. Risk Factors for Early-Onset Colorectal Cancer: Systematic Review and Meta-Analysis. Front Oncol. 2023.
- Gausman V, Dornblaser D, Anand S, et al. Risk Factors Associated With Early-Onset Colorectal Cancer. Clin Gastroenterol Hepatol. 2020.
- Fritz CDL, Otegbeye EE, Zong X, et al. Red-Flag Signs and Symptoms for Earlier Diagnosis of Early-Onset Colorectal Cancer. J Natl Cancer Inst. 2023.
- Demb J, Kolb JM, Dounel J, et al. Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer: Systematic Review and Meta-Analysis. JAMA Netw Open. 2024.
- Eng C, Jácome AA, Agarwal R, et al. A Comprehensive Framework for Early-Onset Colorectal Cancer Research. Lancet Oncol. 2022.
- Rubin R. Rates of Colorectal and Other Cancers Are Rising in Young Adults, Puzzling Researchers. JAMA. 2025.
Screening and clinical guidelines
- Davidson KW, Barry MJ, et al. Screening for Colorectal Cancer: USPSTF Recommendation Statement. JAMA. 2021.
- Jayakrishnan T, Ng K. Early-Onset Gastrointestinal Cancers. JAMA. 2025.
- Issaka RB, Chan AT, Gupta S. AGA Clinical Practice Update on Risk Stratification for Colorectal Cancer Screening and Post-Polypectomy Surveillance. Gastroenterology. 2023.
- Cavestro GM, Mannucci A, Balaguer F, et al. Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines. Clin Gastroenterol Hepatol. 2023.
- NCCN. Colorectal Cancer Screening. National Comprehensive Cancer Network. Actualizado 2025-06-24.
- Sur DKC, Brown PC. Colorectal Cancer Screening and Prevention. Am Fam Physician. 2025.
Genetics, hereditary syndromes and counseling
- Sinicrope FA. Increasing Incidence of Early-Onset Colorectal Cancer. N Engl J Med. 2022.
- Eng C, Jácome AA, Agarwal R, et al. A Comprehensive Framework for Early-Onset Colorectal Cancer Research. Lancet Oncol. 2022.
- Zaborowski AM, Abdile A, Adamina M, et al. Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review. JAMA Surg. 2021.
- Boardman LA, Vilar E, You YN, Samadder J. AGA Clinical Practice Update on Young Adult-Onset Colorectal Cancer Diagnosis and Management. Clin Gastroenterol Hepatol. 2020.
- NCCN. Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric. Actualizado 2025-06-13.
- Stoffel EM, Koeppe E, Everett J, et al. Germline Genetic Features of Young Individuals With Colorectal Cancer. Gastroenterology. 2018.
- Pearlman R, Frankel WL, Swanson B, et al. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer. JAMA Oncol. 2017.
- Hibbert J, Weigl K, Tikk K, et al. Actual and Perceived Risk of Colorectal Neoplasia in First-Degree Relatives of Patients With Colorectal Cancer. Clin Transl Gastroenterol. 2025.
- Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the Care of Individuals With an Inherited Predisposition to Lynch Syndrome. JAMA. 2006.
Lifestyle, diet and prevention
- Carr PR, Weigl K, Jansen L, et al. Healthy Lifestyle Factors Associated With Lower Risk of Colorectal Cancer Irrespective of Genetic Risk. Gastroenterology. 2018.
- Power RF, Doherty DE, Parker I, et al. Modifiable Risk Factors and Risk of Colorectal and Endometrial Cancers in Lynch Syndrome. JCO Precis Oncol. 2023.
- Dashti SG, Win AK, Hardikar SS, et al. Physical Activity and the Risk of Colorectal Cancer in Lynch Syndrome. Int J Cancer. 2018.
- Coletta AM, Peterson SK, Gatus LA, et al. Energy Balance Related Lifestyle Factors and Risk of Endometrial and Colorectal Cancer Among Individuals With Lynch Syndrome. Fam Cancer. 2019.
- Burn J, Sheth H, Elliott F, et al. Cancer Prevention With Aspirin in Hereditary Colorectal Cancer (Lynch Syndrome), CAPP2. Lancet. 2020.
- Chu AH, Lin K, Croker H, et al. Dietary-Lifestyle Patterns and Colorectal Cancer Risk: CUP Global Systematic Review. Am J Clin Nutr. 2025.
- Grewal U, Aggarwal M, Kumar P, et al. Association of lifestyle-related risk factors with incidence and mortality rates of colorectal cancer among adolescents and young adults. J Clin Oncol. 2023.
(and any other references cited in the text as appropriate)
🌍 This article is also available in Spanish. Please use the language switcher in the top menu.
Discover more from Dr. Dándote Salud
Subscribe to get the latest posts sent to your email.
